Dec 9- Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration agreed to review the results of a failed mid-stage trial of a painkiller made with the company's technology designed to deter abuse.» Read More
The Mad Money host calls out the members of Congress who are blocking the XM-Sirius merger from going through.
The head of the organization that insures the nation's commercial banks says there's a need for more transparency in reporting the fortunes and misfortunes of the home mortgage market.
Brewers Anheuser-Busch and Miller Brewing said on Wednesday that several U.S. state Attorneys General have demanded information on how they market and sell caffeinated alcoholic drinks.
The Supreme Court on Wednesday made it harder for consumers to sue manufacturers of federally approved medical devices.
Australia and the United States have agreed to drop restrictions on lucrative trans-Pacific flight routes between the two countries, Australia's government said on Friday.
Regulators said they're reviewing the safety of Allergan's Botox and a competing product after reports of deaths and serious reactions in some patients.
The U.S. is looking into stock sales by a member of French bank Societe Generale's board shortly before the bank announced billions of dollars in losses by a single trader.
The Government of Singapore Investment Corp is prepared to adjust the terms of its deal to buy 9 percent of UBS to help the Swiss bank win shareholder approval, its deputy chairman was quoted as saying on Monday.
Google Inc fired back Sunday at Microsoft's $44.6 billion bid to acquire Yahoo, accusing Microsoft of seeking to extend its computer software monopoly deeper into the Internet realm.
U.S. government prosecutors are investigating whether Swiss banking giant UBS misled investors by reporting inflated prices of mortgage-backed securities it held despite knowing those valuations had eroded, the Wall Street Journal said Saturday.
The top securities regulator in Massachusetts said he has filed civil charges against Merrill Lynch, accusing the brokerage of selling unsuitable subprime mortgage-related securities to the city of Springfield.
U.S. regulators on Friday said Pfizer's anti-smoking drug Chantix appears increasingly likely to be linked to serious psychiatric behavior, and called for stronger label warnings.
The Justice Department on Friday said it is "interested" in reviewing antitrust issues associated with Microsoft nearly $45 billion unsolicited bid for Yahoo.
Merger or no merger, Sirius will be the clear winner of the satellite radio wars, Cramer says. Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
President Bush urged Congress on Friday to quickly pass an economic stimulus package void of extraneous spending, saying only quick action will kickstart the sputtering economy. "I strongly believe it would be a mistake to delay or derail this bill," Bush said.
China's recently introduced price controls are aimed at stabilizing inflationary expectations and will not distort the market economy, planning officials said on Thursday.
The former chief executive of Brocade Communications Systems was sentenced to 21 months in prison for orchestrating a scheme to tamper with the company's records of stock option grants.
The Supreme Court upheld a ruling that investors cannot sue third parties such as banks and accounts in cases of securities fraud.
Beijing has given the final green light to the long-awaited restructuring of China's telecommunications sector that will include a series of mergers to create three industry giants capable of providing a full range of services, the South China Morning Post reported on Friday.
The office of New York Attorney General Andrew Cuomo on Thursday said it launched a formal investigation into Intel to determine whether the world's biggest chipmaker violated state and U.S. antitrust laws to squeeze out its rival, Applied Micro Devices.